A Phase II trial of ELE-02
Latest Information Update: 28 Dec 2022
At a glance
- Drugs ELE 02 (Primary)
- Indications Cardiovascular disorders; Cerebrovascular disorders
- Focus Therapeutic Use
- Sponsors Beckley Psytech; Eleusis
Most Recent Events
- 24 Sep 2019 New trial record